SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-08-065758
Filing Date
2008-10-27
Accepted
2008-10-27 06:04:53
Documents
14
Period of Report
2008-10-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-26779_18k.htm 8-K 23879
2 EX-99.1 a08-26779_1ex99d1.htm EX-99.1 40253
3 EX-99.2 a08-26779_1ex99d2.htm EX-99.2 44137
4 GRAPHIC g267791moi001.gif GRAPHIC 9765
5 GRAPHIC g267791moi002.gif GRAPHIC 17285
6 GRAPHIC g267791moi003.gif GRAPHIC 10021
7 GRAPHIC g267791moi004.gif GRAPHIC 18595
8 GRAPHIC g267791moi005.gif GRAPHIC 20116
9 GRAPHIC g267791moi006.gif GRAPHIC 9773
10 GRAPHIC g267791mmi001.gif GRAPHIC 27758
11 GRAPHIC g267791mmi002.gif GRAPHIC 20323
12 GRAPHIC g267791mmi003.gif GRAPHIC 10678
13 GRAPHIC g267791mmi004.jpg GRAPHIC 40846
14 GRAPHIC g267791mmi005.gif GRAPHIC 13676
  Complete submission text file 0001104659-08-065758.txt   385446
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 081141206
SIC: 2834 Pharmaceutical Preparations